FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileINOVIQ Ltd
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
IIQ.AX
INOVIQ Ltd Stock AnalysisComprehensive stock analysis for INOVIQ Ltd (IIQ.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisIIQ.AX
IIQ.AX
INOVIQ Ltd
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
IIQ.AX
  1. Home
  2. Stocks
  3. INOVIQ Ltd

INOVIQ Ltd

🇦🇺IIQ.AX•ASX

INOVIQ Ltd

🇦🇺IIQ.AX•ASX

Your view on IIQ.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About INOVIQ Ltd

Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Leearne Maree Hinch
Headquarters
23 Normanby Road, Notting Hill, VIC, AU
Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Leearne Maree Hinch
Headquarters
23 Normanby Road, Notting Hill, VIC, AU
Description

INOVIQ Ltd specializes in the research, development, and commercialization of diagnostic and exosome-based products, aiming to improve the detection and treatment of cancer and other conditions across Australia and the United States.

Its current portfolio includes the hTERT test, an immunocytochemistry assay that serves as a supplementary tool for urine cytology in bladder cancer screening, alongside EXO-NET, designed for the capture and isolation of exosomes from liquid biopsy specimens.

The company also boasts a robust diagnostic pipeline, featuring blood tests currently under development for various cancers, including ovarian and breast cancer.

Originally incorporated in 1983 and formerly known as BARD1 Life Sciences Limited until its rebranding to INOVIQ Ltd in December 2021, the company maintains its headquarters in Notting Hill, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for INOVIQ Ltd. Starting points for INOVIQ Ltd: EPS -AUD 0.05, beta 1.62 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for INOVIQ Ltd. INOVIQ Ltd does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for INOVIQ Ltd. Trailing twelve-month EPS for INOVIQ Ltd stands at -AUD 0.05. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 22, 2026
More →

Earnings per share estimates

Per shareThis quarterMar 2026Next quarterJun 2026This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 0.00AUD 0.00−AUD 0.07−AUD 0.06
Lowest estimateAUD 0.00AUD 0.00−AUD 0.10−AUD 0.14
Highest estimateAUD 0.00AUD 0.00−AUD 0.05AUD 0.02
Number of analysts0012
A year ago——−AUD 0.06—
Growth vs a year ago——−28.3%—

Revenue estimates

TotalThis quarterMar 2026Next quarterJun 2026This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 242760.00AUD 202463.00AUD 5.70MAUD 9.40M
Lowest estimateAUD 242760.00AUD 202463.00AUD 4.07MAUD 8.66M
Highest estimateAUD 242760.00AUD 202463.00AUD 7.33MAUD 10.14M
Number of analysts1112
A year ago——AUD 432047.00—
Growth vs a year ago——+1219.3%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for INOVIQ Ltd. INOVIQ Ltd has reported as a listed company since 1988. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold IIQ.AX19 companies
Compare IIQ.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
AGN.AXArgenica Therapeutics LtdHealthcareBiotechnology—
BDX.AXBCAL Diagnostics LimitedHealthcareMedical - Diagnostics & Research—
EMD.AXEmyria LimitedHealthcareMedical - Healthcare Information Services—
EYE.AXNova Eye Medical LimitedHealthcareMedical - Devices—
LGP.AXLittle Green Pharma LtdHealthcareDrug Manufacturers - Specialty & Generic—
MAP.AXMicroba Life Sciences LimitedHealthcareMedical - Diagnostics & Research—
PTX.AXPrescient Therapeutics LimitedHealthcareBiotechnology—
More Medical - Diagnostics & Research companies
TickerTypeCompanySectorExchangeMkt cap
WUXIFWuXi AppTec Co., Ltd.HealthcareOTC$39.8B
XGNExagen Inc.HealthcareNASDAQ$92.1M
SKHHYSonic Healthcare LimitedHealthcareOTC$8.2B
SLDXStella Diagnostics Inc.HealthcareOTC$1.4M
SPDESpeedus Corp.HealthcareOTC$416
SZLSFStageZero Life Sciences Ltd.HealthcareOTC$61,766
TDSGFTelo Genomics Corp.HealthcareOTC$3.8M
TELO.VTelo Genomics Corp.HealthcareTSXV$4.0M
THOXFBioPorto A/SHealthcareOTC$73.8M
TMOThermo Fisher Scientific Inc.HealthcareNYSE$248.1B
TMO.NEThermo Fisher Scientific Inc.HealthcareNEO—
TOMDFTodos Medical Ltd.HealthcareOTC$14,081
Open Comparable Analysis
Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of INOVIQ Ltd.

IIQ.AX AnalysisWeak
Past
1
Growth
1
Health
5
Profit
1
Value
1